Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.

Autor: Leroux-Roels, Geert1, Maes, Cathy1, Clement, Frédéric1, van Engelenburg, Frank2, van den Dobbelsteen, Marieke2, Adler, Michael3, Amacker, Mario4, Lopalco, Lucia5, Bomsel, Morgane6,7,8, Chalifour, Anick9, Fleury, Sylvain9 sylvain.fleury@mymetics.com
Zdroj: PLoS ONE. Feb2013, Vol. 8 Issue 2, p1-15. 15p.
Databáze: Academic Search Ultimate